Severity
Moderate
CPSC recall · Reported January 14, 2021
The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is …
Scalpa Inc., of Phoenix, Ariz. recalled This recall involves Scalpa Numb Maxium Strength Topical Anesthestic Cream in a 10 gram b… - a moderate-severity action.
Scalpa Recalls Scalpa Numb Maximum Strength Topical Anesthetic Cream Due to Failure to Me… was recalled by Scalpa Inc., of Phoenix, Ariz. in January 14, 2021. Reason: The product contains the substance lidocaine which must be in child resistant packaging as required by the Po…. Remedy: Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a sa…. Verify recall #21719 with the CPSC before acting.
The recall
Scalpa Inc., of Phoenix, Ariz. issued this moderate-severity CPSC recall-The product contains the substance lidocaine which must be in child resistant packaging as required by the Po….
Sourced from official CPSC enforcement records. Verify recall #21719 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This CPSC action (record #21719) was formally reported on January 14, 2021. It is classified under Moderate severity, with a current status of Active. Scalpa Inc., of Phoenix, Ariz. is listed as the recalling firm. Federal records list the affected scope as About 10,000.
The documented reason for this recall is: The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of po… Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. The remedy documented by the agency is: Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and contact Scalpa for a full refund or store credit. Scalpa is directly … - consumers holding this product should act on that instruction rather than relying on general guidance.
Within the same product category the archive holds 6 closely related recalls, 6 from CPSC - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 3,731 children & baby products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
About 10,000
Related Recalls
6
6 from same agency
This recall involves Scalpa Numb Maxium Strength Topical Anesthestic Cream in a 10 gram black and white tube with a white cap. "SCALPANUMB" and "Maximum Strength Topical Anesthetic Cream" are printed on the label. The expiration date is marked as EXP 202307 on the crimped end of the tube. Batch number 1000000101, Code: C1 and the UPC code 857076008689 are printed on the outside of the box.
The product contains the substance lidocaine which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning to young children.
Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and contact Scalpa for a full refund or store credit. Scalpa is directly notifying all known purchasers about the recall.
| Attribute | Value |
|---|---|
| Agency | U.S. Consumer Product Safety Commission |
| Severity class | Moderate |
| Status | Active |
| Recall number | 21719 |
| Date reported | January 14, 2021 |
| Date initiated | January 14, 2021 |
| Recalling firm | Scalpa Inc., of Phoenix, Ariz. |
| Affected scope | About 10,000 |
| Distribution | Not disclosed |
| Official source | CPSC notice → |
Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.
What to do with this recall
Consumers should immediately stop using the recalled Scalpa Numb, store the cream in a safe location out of reach of children and…
This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Xishentang Dongguan Trading Co, Ltd., dba Pretty-Life, of China · 2026-07-02
Diamond Wipes International, Inc. of Chino, California · 2026-07-02
· 2026-07-02
· 2026-07-02
Sanven Technology Ltd., dba Vevor, of Rancho Cucamonga, California · 2026-07-02
Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: CPSC, reported January 14, 2021. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.